Why certain brain regions are more affected in Lewy body dementia
Region-Specific Vulnerability of the Lewy Body Dementia's Brain
This project looks at how differences among brain cells in specific regions may lead to symptoms in people with Lewy body dementia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11126573 on NIH RePORTER |
What this research studies
From your perspective, researchers are comparing different brain cell types—neurons, microglia, and astrocytes—across regions like the limbic system and neocortex to learn why some areas break down first. They use single-cell and cell-type specific methods to study α‑synuclein aggregates and how cells communicate, combining human tissue and laboratory models to map patterns of damage. The team will profile cellular and molecular changes region by region to find signals linked to neuron loss and dementia symptoms. Their approach aims to reveal the cellular reasons behind the regional vulnerability seen in Lewy body dementia.
Who could benefit from this research
Good fit: Ideal participants would include people with Lewy body dementia (or related parkinsonian or dementia symptoms) and families willing to donate clinical information or brain tissue for research.
Not a fit: People seeking immediate symptom relief or those without Lewy body dementia are unlikely to receive direct or immediate benefit from this basic research.
Why it matters
Potential benefit: If successful, this work could point to specific cells or pathways to target for future treatments that slow or prevent brain damage in Lewy body dementia.
How similar studies have performed: Related single-cell and cell-type studies in Alzheimer's and Parkinson's disease have produced useful insights, but region-focused work specifically for Lewy body dementia is relatively new.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Na, Chan-Hyun — Johns Hopkins University
- Study coordinator: Na, Chan-Hyun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.